Exane Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Exane Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$2.03M	–	39
2019 Q3	$2.03M	Buy	+30,000	New	+$2.06M	1.56%	17

Exane Asset Management's GHDX Position: Q4 2019 in Review

Exane Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 30,000 shares — an estimated $2.03M sold.

Exane Asset Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $2.03M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Exane Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Exane Asset Management sold 30,000 Genomic Health, Inc. shares in Q4 2019, an estimated $2.03M.
Exane Asset Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
Exane Asset Management's Genomic Health, Inc. position peaked at $2.03M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Exane Asset Management's 13F filing for Q4 2019, filed 3 Feb 2020.